Related Experiment Videos
AIDS vaccine development: the long and winding road
David A Garber1, Mark B Feinberg
1Emory Vaccine Research, Atlanta, GA, USA.
AIDS Reviews
|November 6, 2003
Summary
Developing an effective AIDS vaccine is challenging. Current strategies focus on CD8+ T-cell responses to control HIV replication and slow disease progression, rather than preventing infection entirely.
Area of Science:
- Immunology
- Vaccinology
- Virology
Background:
- Sterilizing immunity against HIV is difficult due to challenges in generating neutralizing antibodies.
- Current HIV vaccine research shifts focus to eliciting CD8+ T-cell responses.
Purpose of the Study:
- To discuss the promise and limitations of current AIDS vaccine development strategies.
- To explore scientific challenges in creating effective AIDS vaccines.
Main Methods:
- Review of pre-clinical studies on CTL-based vaccines in non-human primate models.
- Evaluation of heterologous prime/boost strategies (e.g., DNA + viral vectors).
Main Results:
- Vaccine modalities can elicit high-level cellular immune responses.
- These responses are associated with limited virus replication and protection in animal models.
Conclusions:
- Translating animal model protection to humans remains uncertain.
- Further research is needed to overcome scientific challenges for a safe and effective AIDS vaccine.